
Cat. #161038
NCI-HPN-F1D-Kid
Cat. #: 161038
Availability: 8-10 weeks
Organism: Mouse
Tissue: Epithelial
Disease: Cancer
£575.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Hesed Padilla-Nash
Institute: NIH/NCI
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: NCI-HPN-F1D-Kid
- Cancer type: Kidney cancer
- Cancers detailed: Kidney
- Research fields: Cancer
- Organism: Mouse
- Tissue: Epithelial
- Disease: Cancer
- Crispr: No
- Description: Mouse epithelial cancer cell line derived from the kidney.? These cells lines were obtained from spontaneously transformed primary cell cultures without genetic, viral or chemical manipulation so they can serve as mouse models for studying the natural process of oncogenesis.?Â
- Biosafety level: 1
Handling
- Growth medium: DMEM/F12 media without phenol-red indicator (Invitrogen)
- Temperature: 37° C
- Atmosphere: 5% CO2
- Shipping conditions: Dry Ice
- Mycoplasma free: Yes
References
- Padilla-Nash HM et al. 2012. Genes Chromosomes Cancer. Apr
- 51(4):353-74. PMID: 22161874
- PMCID: PMC3276715
![Anti-CAR Whitlow Linker [1C3C3]](https://cancertools.org/wp-content/uploads/Figure-6-Kimble-et-al.-J-Immunother-Cancer-2025-300x322.jpg 300w, https://cancertools.org/wp-content/uploads/Figure-6-Kimble-et-al.-J-Immunother-Cancer-2025-280x300.jpg 280w, https://cancertools.org/wp-content/uploads/Figure-6-Kimble-et-al.-J-Immunother-Cancer-2025-954x1024.jpg 954w, https://cancertools.org/wp-content/uploads/Figure-6-Kimble-et-al.-J-Immunother-Cancer-2025-768x824.jpg 768w, https://cancertools.org/wp-content/uploads/Figure-6-Kimble-et-al.-J-Immunother-Cancer-2025.jpg 1193w)

![Anti-CAR Whitlow Linker [1B4A1]](https://cancertools.org/wp-content/uploads/Figure-5-Kimble-et-al.-J-Immunother-Cancer-2025-300x396.jpg 300w, https://cancertools.org/wp-content/uploads/Figure-5-Kimble-et-al.-J-Immunother-Cancer-2025-227x300.jpg 227w, https://cancertools.org/wp-content/uploads/Figure-5-Kimble-et-al.-J-Immunother-Cancer-2025-776x1024.jpg 776w, https://cancertools.org/wp-content/uploads/Figure-5-Kimble-et-al.-J-Immunother-Cancer-2025-768x1013.jpg 768w, https://cancertools.org/wp-content/uploads/Figure-5-Kimble-et-al.-J-Immunother-Cancer-2025.jpg 970w)

